Acro Biotech Inc. – Trademark Portfolio

Entity Type: 03

Acro Biotech Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 11 filings in this category. Currently, 9 trademarks are registered. Notable registered marks include APOKI, APOTI, BEACAN, CITODIA, and JUSCHEK. The owner is based in Montclair, CA.

4650 Arrow Hwy Suite D6

Montclair, CA 91763

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OPTILYTE
OPTILYTE
Abandoned 2019
INSTEST
INSTEST
Abandoned 2019
BEACAN
BEACAN
Registered 2019
APOKI
APOKI
Registered 2019
DIABEPRO
DIABEPRO
Registered 2019
CITODIA
CITODIA
Registered 2019
APOTI
APOTI
Registered 2019
FLUROLIT
FLUROLIT
Registered 2019
JUSCHEK
JUSCHEK
Registered 2018

Trademark Classifications

Acro Biotech Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (11 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Acro Biotech Inc. have?

Acro Biotech Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 9 registered, 2 abandoned.

What trademark classes does Acro Biotech Inc. file in?

Acro Biotech Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Acro Biotech Inc.'s most well-known trademarks?

Acro Biotech Inc.'s registered trademark portfolio includes well-known marks such as APOKI, APOTI, BEACAN, CITODIA, and JUSCHEK. These are among 9 currently registered trademarks in the portfolio.

What is Acro Biotech Inc.'s trademark registration success rate?

Acro Biotech Inc. has a 82% trademark registration rate, with 9 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.